Patents by Inventor Simon Lillico

Simon Lillico has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals
    Patent number: 9854790
    Abstract: The present invention relates to methods and compositions useful for the prevention and/or treatment of PRRS in animals, typically domestic pigs. The invention relates to proteins which comprise fragments of CD163, nucleic acid constructs encoding such proteins, and methods of modifying expression or activity of CD 163 in vivo.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: January 2, 2018
    Assignee: The University Court of the University of Edinburgh
    Inventors: Tahar Ait-Ali, Simon Lillico, Alan Archibald, Christopher Bruce Alexander Whitelaw
  • Domain 5 of CD163 for Use in Antiviral Compositions Against PRRS, and Transgenic Animals
    Publication number: 20160165860
    Abstract: The present invention relates to methods and compositions useful for the prevention and/or treatment of PRRS in animals, typically domestic pigs. The invention relates to proteins which comprise fragments of CD163, nucleic acid constructs encoding such proteins, and methods of modifying expression or activity of CD163 in vivo.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 16, 2016
    Applicant: The University Court of the University of Edinburg h
    Inventors: Tahar Ait-Ali, Simon Lillico, Alan Archibald, Christopher Bruce Alexander Whitelaw
  • TRANSGENIC PIG FOR MUTANT GUCY2D AS CONE DYSTROPHY MODEL
    Publication number: 20140033333
    Abstract: The present invention relates to a transgenic pig as a model for studying a cone affecting disease, in particular a cone dystrophy or cone-rod-dystrophy, wherein the pig model expresses a dominant negative guanylate-cyclase-2D (GUCY2D) protein, in particular a GUCY2D protein comprising at least one mutation responsible for the appearance of a CORD6 cone dystrophy in a human being. The invention further relates to methods by which the transgenic pig is produced, to uses of said transgenic pig or of one of its elements to identify new biomarkers of a cone affecting disease and/or new compounds for preventing or treating such a disease. Novel methods for preventing or treating a cone affecting disease or for evaluating conditions needed to alleviate such a disease are further herein described.
    Type: Application
    Filed: January 27, 2012
    Publication date: January 30, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASILE DES AVEUGLES
    Inventors: Chamsy Sarkis, Christopher Bruce Alexander Whitelaw, Simon Lillico, Corinne Kostic, Yvan Arsenijevic